Urotronic Inc.
Clinical trials sponsored by Urotronic Inc., explained in plain language.
-
New balloon procedure targets troubling prostate symptoms
Disease control CompletedThis study tested a new medical device called the Optilume BPH catheter in 80 men with moderate-to-severe urinary symptoms from an enlarged prostate. The device is a small balloon coated with a drug (paclitaxel) that is inflated inside the prostate to open the urinary passage. Re…
Phase: PHASE2 • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New balloon treatment aims to stop painful urinary blockages from coming back
Disease control CompletedThis study tested a special balloon coated with a scar-reducing drug to treat men with recurring urethral strictures (narrowing of the urine tube). The goal was to see if inflating this balloon in the narrowed area could safely keep it open longer than previous treatments. It inv…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC